A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
for Neuroblastoma
Drug: Cabozantinib
6 locations incl. Birmingham
Sponsor: Nationwide Children's Hospital
Sex: All·Age: 18 Months - 40
Code: NCT05135975·Phase 2·Recruiting